What is Alexis Erlach's NPI number?

Alexis Erlach's National Provider Identifier (NPI) is 1003486192, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.

What is Alexis Erlach's specialty?

Alexis Erlach is listed in the NPPES registry with a primary specialty of Family Nurse Practitioner (Physician Assistants & Advanced Practice Nursing Providers).

Where is Alexis Erlach located?

Alexis Erlach's practice location on file with NPPES is 555 N Arlington Ave, Reno, NV 89503-4723.

What is Alexis Erlach's phone number?

The practice phone number listed in the NPPES registry for Alexis Erlach is (775) 786-3040.

Does Alexis Erlach accept Medicare?

Alexis Erlach is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.

Is Alexis Erlach's NPI active?

Yes — Alexis Erlach's NPI (1003486192) is active in the NPPES registry as of the last update on 2026-04-21.

IndividualActiveAccepts Medicare

Alexis Erlach, APRN

NPI 1003486192 · Family Nurse Practitioner · Reno, NV

Alexis Erlach, APRN is a Family Nurse Practitioner provider in Reno, NV (NPI 1003486192).

Provider details

NPI number: 1003486192
Entity type: Individual
Primary specialty: Family Nurse PractitionerPhysician Assistants & Advanced Practice Nursing Providers
Credential: APRN
Sex: Female
Sole proprietor: No
License: 842492 (NV)

Practice location

555 N Arlington Ave

Reno, NV 89503-4723

Phone: (775) 786-3040

Fax: (775) 788-5216

Street-level locationGet directions

More NV providers

Mailing address

555 N Arlington Ave

Reno, NV 89503-4723

Specialties & taxonomies

Family Nurse PractitionerPrimary363LF0000XLicense 842492 (NV)
Physician Assistants & Advanced Practice Nursing Providers

Enrolled with Medicare as Practitioner - Nurse Practitioner · source: CMS PECOS Public Provider Enrollment (2026.04.01)

Profile Score

Established profile(61/100 index)

A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.

Registry tenure25% of score
5 yrs in NPPES registry
Profile completeness25% of score
100% of core fields populated
Practice footprint15% of score
1 documented practice location
Medicare service volume (vs. specialty peers)25% of score
477 Medicare services, 2024 (ranked within specialty)
Open Payments transparency10% of score
Has Open Payments disclosures (2024)

Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our methodology.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Destruction of Precancer Skin Growth, 2-14 Growths17003	176	$5
Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213	86	$76
Biopsy of Related Skin Growth, First Growth11102	46	$70
Destruction of Precancer Skin Growth, 1 Growth17000	42	$41
Destruction of Skin Growth, 1-14 Growths17110	39	$92
Biopsy of Related Skin Growth, Each Additional Growth

What this provider prescribes (Medicare Part D)

Top drugs by Medicare Part D claim volume, 2024 · 7 distinct drugs on file.

Drug	Part D claims (2024)	Beneficiaries
Mupirocin	45	25
Triamcinolone Acetonide	38	25
Ketoconazole	26	12
Clobetasol Propionate	25	11
Tralokinumab-Ldrmbrand: Adbry	17	—
Doxycycline Hyclate	12	—
Hydroxyzine Hcl	12	—

Medicare Part D only. These counts cover prescriptions paid through Medicare Part D in 2024 — they do not include cash-pay, commercial-insurance, Medicaid, or Part B–administered drugs, and badly undercount high cash-pay categories (e.g. GLP-1 weight-loss, testosterone, and ED medications). Any drug with 10 or fewer claims is omitted by CMS, and beneficiary counts under 11 are suppressed — so a missing drug means , never zero. This is a factual claims summary, not an endorsement, not medical advice, and not a consumer report. Source: CMS Medicare Part D Prescribers — by Provider and Drug.

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$1,487 across 64 records (Open Payments 2024)

Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.

Enumerated: 2021-06-30
Last updated: 2026-04-21
Certified: 2026-04-21

Frequently asked questions

What is Alexis Erlach's NPI number?: Alexis Erlach's National Provider Identifier (NPI) is 1003486192, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
What is Alexis Erlach's specialty?: Alexis Erlach is listed in the NPPES registry with a primary specialty of Family Nurse Practitioner (Physician Assistants & Advanced Practice Nursing Providers).
Where is Alexis Erlach located?: Alexis Erlach's practice location on file with NPPES is 555 N Arlington Ave, Reno, NV 89503-4723.
What is Alexis Erlach's phone number?: The practice phone number listed in the NPPES registry for Alexis Erlach is (775) 786-3040.
Does Alexis Erlach accept Medicare?: Alexis Erlach is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
Is Alexis Erlach's NPI active?: Yes — Alexis Erlach's NPI (1003486192) is active in the NPPES registry as of the last update on 2026-04-21.

Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Destruction of Precancer Skin Growth, 2-14 Growths17003	176	$5
Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213	86	$76
Biopsy of Related Skin Growth, First Growth11102	46	$70
Destruction of Precancer Skin Growth, 1 Growth17000	42	$41
Destruction of Skin Growth, 1-14 Growths17110	39	$92
Biopsy of Related Skin Growth, Each Additional Growth

What this provider prescribes (Medicare Part D)

Top drugs by Medicare Part D claim volume, 2024 · 7 distinct drugs on file.

Drug	Part D claims (2024)	Beneficiaries
Mupirocin	45	25
Triamcinolone Acetonide	38	25
Ketoconazole	26	12
Clobetasol Propionate	25	11
Tralokinumab-Ldrmbrand: Adbry	17	—
Doxycycline Hyclate	12	—
Hydroxyzine Hcl	12	—

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$1,487 across 64 records (Open Payments 2024)

Provider details

Practice location

Mailing address

Specialties & taxonomies

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments

Registry dates

Frequently asked questions

Specialties & taxonomies

Frequently asked questions

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments